Cornerstones of Fair Drug Coverage
This guideline provides ethical principles and fair design criteria for drug coverage policies, focusing on cost sharing, eligibility rules, and step therapy. It helps ensure that patients have fair access to medications while keeping healthcare affordable.
At a glance
Use when
Designing or evaluating pharmaceutical coverage policies; addressing ethical concerns in cost sharing or step therapy; engaging stakeholders in benefit design
Avoid when
Detailed economic modeling is required; a technical evaluation tool is needed; implementation-level operational guidance is the primary objective
Inputs
Pharmaceutical benefit design policies, stakeholder values, ethical considerations in access to care
Outputs
Fair design criteria for drug coverage, ethical goals for access, guidance for transparent and accountable decision-making
How it works
The framework outlines ethical goals for access and proposes fair design criteria for three controversial areas in pharmaceutical coverage: cost-sharing provisions, clinical eligibility criteria, and economic-step therapy or required switching. These criteria aim to balance patient-clinician autonomy with affordability and accountability in health insurance programs.
- HTA domains
- Organisational aspects, Patient and Social Aspects, Aspects Beyond HTA
- Assumptions
- Healthcare resources are limited;公平 access requires balancing individual needs with systemic affordability; stakeholders can apply ethical criteria to coverage design
- Strengths
- Provides a structured ethical framework; applicable across different health systems; promotes transparency and accountability in coverage decisions
- Limitations
- Does not provide quantitative modeling or implementation tools; focused on ethical principles rather than operational guidance
- Also known as
- Fair Drug Coverage Framework
Questions this answers
- › How can cost-sharing in drug coverage be designed fairly?
- › What ethical goals should guide access to pharmaceuticals?
- › When is step therapy or required switching ethically justifiable?
- › How can clinical eligibility criteria support equitable access?
- › What principles ensure transparency in drug coverage decisions?
- › How can stakeholders assess the fairness of utilization management policies?
References & sources
Similar by meaning
- Open and Fair — Norwegian Priority-Setting Criteria (NOU 2014:12, Norheim Committee)
- Principles for Deliberative Processes in HTA
- Guidance on priority setting in health care (GPS-Health)
- Checklist to guide equity considerations in HTA
- Key Principles for the Improved Conduct of Health Technology Assessments for Resource Allocation Decisions
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.